ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 130 filers reported holding ENDOLOGIX INC in Q1 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $10,144,000 | -41.0% | 2,087,238 | -12.0% | 0.66% | -37.5% |
| Q1 2017 | $17,180,000 | +7.2% | 2,372,991 | -15.3% | 1.05% | -2.9% |
| Q4 2016 | $16,024,000 | -42.6% | 2,801,461 | +28.4% | 1.08% | -41.2% |
| Q3 2016 | $27,933,000 | +51.2% | 2,182,278 | +47.2% | 1.84% | +39.7% |
| Q2 2016 | $18,477,000 | +71.0% | 1,482,885 | +14.7% | 1.32% | +64.8% |
| Q1 2016 | $10,805,000 | -4.2% | 1,292,432 | +13.4% | 0.80% | -0.5% |
| Q4 2015 | $11,279,000 | +85.9% | 1,139,313 | +130.3% | 0.80% | +63.9% |
| Q3 2015 | $6,066,000 | +62.9% | 494,743 | +102.1% | 0.49% | -51.6% |
| Q2 2014 | $3,723,000 | +92.7% | 244,795 | +63.0% | 1.01% | +21.8% |
| Q1 2014 | $1,932,000 | -1.8% | 150,146 | +33.1% | 0.83% | -41.2% |
| Q4 2013 | $1,968,000 | – | 112,839 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Capital Management, LLC | 4,050,000 | $49,653,000 | 5.91% |
| Essex Woodlands Management, Inc. | 1,257,468 | $21,220,000 | 3.88% |
| PURA VIDA INVESTMENTS, LLC | 205,100 | $2,515,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,347,113 | $28,776,000 | 1.11% |
| First Light Asset Management, LLC | 180,963 | $2,219,000 | 1.10% |
| ArrowMark Colorado Holdings LLC | 2,889,546 | $35,426,000 | 0.97% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,149,949 | $26,358,000 | 0.78% |
| Iguana Healthcare Management, LLC | 150,000 | $1,839,000 | 0.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,492,443 | $18,297,000 | 0.66% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 85,882 | $1,053,000 | 0.66% |